Autor Título Original / Colaboración Selecciona una opción Original Colaboración Año Selecciona un año20152016201720182019202020212022202320242025 Cuartil Selecciona un cuartilD1Q1Q2Q3Q4 Tipo Selecciona un tipo#N/DArticleArtículoBook ChapterBook ReviewClinical TrialCommentaryCorrectionData PaperEditorialEditorial MaterialExpression of ConcernLetterProceedings PaperReprintReview Revista Antibody Response 3 Months after 2 Doses of BNT162b2 mRNA COVID-19 Vaccine in Residents of Long-Term Care Facilities Autores: Causa, R; Almagro-Nievas, D; Rivera-Izquierdo, M; Benitez-Munoz, N; Lopez-Hernandez, B; Garcia-Garcia, F; Alvarez-Estevez, M; Soto-Perez, MD; Bermudez-Tamayo, C Identification of IL-6 Signalling Components as Predictors of Severity and Outcome in COVID-19. Autores: Rodriguez-Hernandez, MA; Carneros, D; Nunez-Nunez, M; Coca, R; Baena, R; Lopez-Ruiz, GM; Cano-Serrano, ME; Martinez-Telleria, A; Fuentes-Lopez, A; Praena-Fernandez, JM; Garbers, C; Hernandez-Quero, J; Garcia, F; Rose-John, S; Bustos, M ESCMID COVID-19 guidelines: diagnostic testing for SARS-CoV-2 Autores: Fragkou, PC; De Angelis, G; Menchinelli, G; Can, FS; Garcia, F; Morfin-Sherpa, F; Dimopoulou, D; Mack, E; de Salazar, A; Grossi, A; Lytras, T; Skevaki, C Effect of tocilizumab versus standard of care in adults hospitalized with moderate-severe COVID-19 pneumonia Autores: Aomar-Millan, IF; Salcaterra, J; Alvarez, ER Hospitalization and mortality from COVID-19 of patients with rheumatic inflammatory diseases in Andalusia Autores: Mena-Vazquez, N; Arija, SM; Rojas-Gimenez, M; Raya-Alvarez, E; Velloso-Feijoo, ML; Lopez-Medina, C; Ramos-Giraldez, C; Godoy-Navarrete, FJ; Redondo-Rodriguez, R; Cabezas-Lucena, AM; Morales-Aguila, M; Romero-Barco, CM; Fernandez-Nebro, A Psychological and quality of life effects of vaccination against COVID-19 in patients with systemic autoimmune diseases Autores: Montero-Lopez, E; Peralta-Ramirez, MI; Ortego-Centeno, N; Callejas-Rubio, JL; Rios-Fernandez, R; Santos-Ruiz, A Resistance training and clinical status in patients with postdischarge symptoms after COVID-19: protocol for a randomized controlled crossover trial The EXER-COVID Crossover Study Autores: Ramirez-Velez, R; Oteiza, J; de Tejerina, JMCF; Garcia-Alonso, N; Legarra-Gorgonon, G; Oscoz-Ochandorena, S; Arasanz, H; Garcia-Alonso, Y; Correa-Rodriguez, M; Izquierdo, M < 1 2 … 22 23 24 … 44 45 >